Whistle-blower: Walgreen saw "unique opportunity" to substitute more expensive meds

09/13/2011 | BNET

A whistle-blower lawsuit accuses Walgreen executives of encouraging pharmacists to switch patients' Zantac tablet prescriptions to a Par Pharmaceuticals capsule version that cost up to three times as much. Par representatives alerted Walgreen managers that Medicaid limited reimbursement for the tablet version but not for the capsule version. Walgreen's director of pharmacy marketing allegedly told pharmacists that substituting the easier-to-swallow capsules for the tablets was "a unique opportunity" to interact with patients.

View Full Article in:

BNET

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC